Qynapse Revenue and Competitors
Estimated Revenue & Valuation
- Qynapse's estimated annual revenue is currently $2.5M per year.
- Qynapse's estimated revenue per employee is $98,000
Employee Data
- Qynapse has 25 Employees.
- Qynapse grew their employee count by 9% last year.
Qynapse's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Scientific Officer | Reveal Email/Phone |
2 | Chief Product and Technical Officer | Reveal Email/Phone |
3 | Chief Financial Officer | Reveal Email/Phone |
4 | Director R&D Imaging | Reveal Email/Phone |
5 | Quality and Regulatory Affairs Director | Reveal Email/Phone |
6 | Product Manager | Reveal Email/Phone |
7 | Full Stack Engineer | Reveal Email/Phone |
8 | Architecte cloud | Reveal Email/Phone |
9 | Operations Lead | Reveal Email/Phone |
10 | AI Engineer (medical imaging) | Reveal Email/Phone |
Qynapse Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1M | 12 | -66% | N/A | N/A |
#2 | $9.5M | 75 | -18% | N/A | N/A |
#3 | $1.5M | 18 | -14% | N/A | N/A |
#4 | $14.7M | 105 | 2% | N/A | N/A |
#5 | $18.2M | 130 | 11% | N/A | N/A |
#6 | $3.6M | 32 | 19% | N/A | N/A |
#7 | $2.5M | 25 | 9% | N/A | N/A |
#8 | $1.2M | 14 | -22% | N/A | N/A |
#9 | $8.9M | 71 | 69% | N/A | N/A |
#10 | $3.9M | 35 | -12% | N/A | N/A |
What Is Qynapse?
Qynapse is a medical technology company that provides a cloud-based platform for the diagnosis, prognosis and drug efficacy measurement for central nervous system diseases (such as multiple sclerosis, Alzheimer's, Parkinson's and ischemic stroke). Qynapse is a spin-off of the CATI consortium of neuroimaging research laboratories and is headquartered in Paris.
keywords:N/AN/A
Total Funding
25
Number of Employees
$2.5M
Revenue (est)
9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $4.7M | 25 | 0% | N/A |
#2 | $2.5M | 25 | N/A | N/A |
#3 | $2.5M | 25 | N/A | N/A |
#4 | $2.5M | 25 | N/A | N/A |
#5 | $2.5M | 25 | -4% | N/A |